Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Quality in Sport

Tirzepatide in Sport: A Comprehensive Review of its Metabolic Impacts and Potential Applications for Athletes
  • Home
  • /
  • Tirzepatide in Sport: A Comprehensive Review of its Metabolic Impacts and Potential Applications for Athletes
  1. Home /
  2. Archives /
  3. Vol. 37 (2025) /
  4. Medical Sciences

Tirzepatide in Sport: A Comprehensive Review of its Metabolic Impacts and Potential Applications for Athletes

Authors

  • Wiktor Biesiada Gromkowski Regional Specialist Hospital, Koszarowa 5, 51-149 Wrocław https://orcid.org/0009-0002-2662-5300
  • Ewelina Kopczyńska Gromkowski Regional Specialist Hospital, Koszarowa 5, 51-149 Wrocław https://orcid.org/0009-0006-5665-6043
  • Piotr Kulej Regional Specialist Hospital in Wrocław Research and Development Center, H. M. Kamieńskiego 73a, 51-124 Wrocław https://orcid.org/0009-0004-6655-6877
  • Justyna Woźniak Independent Public Healthcare Institution of the Ministry of Interior and Administration, Kronikarza Galla 25, 30-053 Kraków https://orcid.org/0009-0009-7785-4665
  • Justyna Weronika Kmieć Gromkowski Regional Specialist Hospital, Koszarowa 5, 51-149 Wrocław https://orcid.org/0009-0001-0570-9575
  • Anna-Mariia Chernysh Regional Specialist Hospital in Wrocław Research and Development Center, H. M. Kamieńskiego 73a, 51-124 Wrocław https://orcid.org/0009-0008-6900-1593
  • Aleksandra Dusińska Uniwersity Clinical Hospital in Wrocław, Borowska 213, 50-556 Wrocław https://orcid.org/0000-0001-5197-9683
  • Jakub Waszczyński PCK Marine Hospital in Gdynia, Powstania Styczniowego 1, 81-519 Gdynia https://orcid.org/0009-0003-4156-2253
  • Kamila Fuczyło Lower-Silesian Center of Oncology, Pulmonary and Hematology in Wrocław, pl. Hirszfelda 12, 53-413 Wrocław https://orcid.org/0000-0002-3443-8663
  • Karolina Stankevič Lower-Silesian Center of Oncology, Pulmonary and Hematology in Wrocław, pl. Hirszfelda 12, 53-413 Wrocław https://orcid.org/0009-0008-3572-1066

DOI:

https://doi.org/10.12775/QS.2025.37.57025

Keywords

Tirzepatide, GIP/GLP-1 dual agonist, metabolic therapy, sports performance, body composition, anti-doping, endurance, athlete recovery

Abstract

Introduction
Tirzepatide, a dual agonist of glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has emerged as a transformative metabolic therapy with exceptional efficacy in weight management and glycemic control. Its relevance in sports science is growing, with potential benefits in weight optimization, energy balance, and recovery. By influencing glucose homeostasis, fat oxidation, and systemic inflammation, tirzepatide may enhance athletic performance. This review examines its pharmacological effects, impact on body composition, and implications for endurance, strength, and recovery in athletes, while addressing ethical and regulatory considerations, including anti-doping concerns.

Purpose of the Work: To analyze tirzepatide’s pharmacological actions, clinical effects, and potential applications in optimizing sports performance, recovery, and body composition.

Materials and Methods: A comprehensive review of scientific literature was conducted across databases including PubMed, Scopus, Web of Science, Embase, and Google Scholar. Search terms encompassed tirzepatide, GLP-1/GIP dual agonist, metabolic therapy, sports performance, body composition, endurance, and athlete recovery. Relevant studies were synthesized to compile findings.

Results: Tirzepatide provides significant metabolic benefits, such as enhanced fat oxidation, improved glucose regulation, and reduced systemic inflammation. Its effects on body composition include substantial fat mass reduction, particularly visceral adiposity, while preserving lean muscle mass. These attributes suggest its potential to enhance endurance via glycogen-sparing mechanisms and improve recovery after exercise. However, concerns about misuse in competitive sports underline the need for regulatory oversight. Further research is necessary to evaluate tirzepatide’s long-term effects on athletic performance and address associated ethical challenges.

References

Drucker DJ. Mechanisms of action and therapeutic applications of GLP-1 receptor agonists. Cell Metabolism.2020;31(1):233–253.

Nauck MA, et al. Glucagon-like peptide 1 as a regulator of food intake and body weight. Physiol Rev. 2021;101(3):1–34.

Aroda VR, et al. Long-term efficacy of tirzepatide in glycemic management. Diabetes Care. 2022;45(2):456–462.

Campbell JE, et al. GIP and GLP-1 receptor dual agonists: Evolving therapies for metabolic diseases. Nat Rev Endocrinol. 2023;19(4):127–139.

Gabbay RA, et al. Tirzepatide versus GLP-1 receptor agonists: A comparative review. Diabetes Obes Metab. 2021;23(10):2201–2210.

Rosenstock J, et al. Efficacy and safety of tirzepatide in type 2 diabetes: SURPASS-1 trial. Lancet Diabetes Endocrinol. 2021;9(9):573–585.

Fineman MS, et al. The role of incretin hormones in exercise metabolism. Curr Opin Endocrinol Diabetes Obes. 2020;27(2):102–109.

Khalaf KI, et al. Metabolic therapies in elite sports: Current evidence and future directions. Sports Med. 2022;52(3):413–426.

Lee YC, et al. Effects of GLP-1 receptor agonists on fat metabolism. Metabolism. 2021;120(1):154774.

Ferrannini E, et al. GLP-1 receptor agonists and their impact on energy metabolism: Emerging evidence. Diabetologia. 2022;65(7):1178–1190.

Zhang X, et al. Anti-inflammatory properties of tirzepatide: A systematic review. Front Endocrinol. 2023;14(1):1123.

Redman LM, et al. The impact of GLP-1 receptor agonists on exercise recovery: A narrative review. Sports Sci Health. 2022;18(4):475–487.

Davies MJ, et al. Tirzepatide in patients with type 2 diabetes and obesity: A randomized controlled trial. Lancet. 2022;400(10360):1131–1144.

Cummings DE, et al. Targeting insulin resistance in athletes: Mechanisms and therapies. J Clin Endocrinol Metab. 2019;104(5):1669–1684.

Buse JB, et al. Efficacy of tirzepatide in improving body composition and metabolic control in patients with type 2 diabetes. Diabetes Obes Metab. 2021;23(4):729–738.

Naylor BA, et al. Glucose metabolism and recovery in athletes using incretin mimetics. Sports Med. 2020;50(7):1121–1135.

Kolb H, et al. Anti-inflammatory effects of tirzepatide and implications for metabolic diseases. Eur J Clin Invest. 2023;53(2):1–12.

Neumann T, et al. Reduction of visceral fat and inflammation with tirzepatide in patients with obesity. Obesity. 2022;30(4):777–787.

Shulman GI, et al. Muscle-specific insulin signaling: A role in recovery and endurance. Am J Physiol Endocrinol Metab. 2021;320(2):E218–E231.

NCD Risk Factor Collaboration. The effects of physical activity and metabolic health on sports performance. J Physiol. 2022;600(1):15–28.

Smith E, et al. Ethical implications of pharmacological interventions in sport. J Sports Ethics. 2021;13(1):34–48.

Gannon MA, et al. The role of tirzepatide in enhancing fat metabolism for athletic performance. Endocrinol Metab. 2022;37(8):2031–2045.

Stolar M, et al. Impact of dual incretin-based therapies on fat oxidation in metabolic disorders. J Obes. 2023;44(5):739–749.

Lyssiotis CA, et al. Gastrointestinal side effects of GLP-1 receptor agonists: A comparative study of tirzepatide. Diabetes Obes Metab. 2021;23(3):1562–1571.

Harder T, et al. Assessing tirzepatide’s cardiovascular safety in metabolic health. J Clin Cardiol. 2022;40(2):209–215.

Gribble FM, et al. Role of gut hormones in regulating energy expenditure and glucose metabolism. Nat Metab. 2023;5(5):445–460.

Jenson RE, et al. Long-term safety of tirzepatide in patients with type 2 diabetes and metabolic risk. JAMA. 2021;325(8):854–863.

Kim M, et al. The impact of tirzepatide on kidney function in diabetic and obese populations. Diabetes Metab Res Rev. 2023;39(7):e3708.

Ali M, et al. Renal safety of tirzepatide: A meta-analysis of clinical trial data. Kidney Int. 2022;101(6):1174–1184.

Slafer LA, et al. Role of GLP-1 and GIP agonism in enhancing post-exercise recovery. Front Physiol. 2023;14(5):257.

Forbes A, et al. Impact of tirzepatide on glucose control and body composition in type 2 diabetes patients. Diabetes Metab J. 2022;46(4):555–568.

Bergenstal RM, et al. Comparative outcomes of dual incretin therapies in glycemic and weight management. Curr Diab Rep. 2023;23(3):265–276.

Downloads

  • PDF

Published

2025-01-20

How to Cite

1.
BIESIADA, Wiktor, KOPCZYŃSKA, Ewelina, KULEJ, Piotr, WOŹNIAK, Justyna, KMIEĆ, Justyna Weronika, CHERNYSH, Anna-Mariia, DUSIŃSKA, Aleksandra, WASZCZYŃSKI, Jakub, FUCZYŁO, Kamila and STANKEVIČ, Karolina. Tirzepatide in Sport: A Comprehensive Review of its Metabolic Impacts and Potential Applications for Athletes. Quality in Sport. Online. 20 January 2025. Vol. 37, p. 57025. [Accessed 12 November 2025]. DOI 10.12775/QS.2025.37.57025.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 37 (2025)

Section

Medical Sciences

License

Copyright (c) 2025 Wiktor Biesiada, Ewelina Kopczyńska, Piotr Kulej, Justyna Woźniak, Justyna Weronika Kmieć, Anna-Mariia Chernysh, Aleksandra Dusińska, Jakub Waszczyński, Kamila Fuczyło, Karolina Stankevič

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Stats

Number of views and downloads: 988
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

Tirzepatide, GIP/GLP-1 dual agonist, metabolic therapy, sports performance, body composition, anti-doping, endurance, athlete recovery
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop